Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nova Mentis Life Science Corp. C.LIB

Healthcare Drug Manufacturers - Major Cannabis
Nova Mentis Life Science Corp is a Canadian-based company focused on building and supporting a diversified portfolio of health and wellness businesses. Through its subsidiary, the company is focused on exploring the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes and providing a Health Canada Standard Licensed facility focused on the cultivation of AAAA premium, small batch, terpene rich dominant cultivars cured to perfection.


CSE:LIB - Post by User

Nova Mentis Life Science Corp. > ACB buying LIB
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by Bellseyon Nov 24, 2017 11:54am
141 Views
Post# 27025612

RE:RE:RE:RE:RE:RE:RE:RE:RE:ACB buying LIB

RE:RE:RE:RE:RE:RE:RE:RE:RE:ACB buying LIBI think we will see the rejection of big-weed in parts of the recreational market. I don't think there will be much rejection in the medicinal market. Occassional users will likely have no issue buying from APH/WEED/ACB -afterall, they will have the lowest prices. Heavy users will look for the best mj, which may end up being the craft/artisan varieties. 

In BC, I think craft cannabis will be huge. GUESS WHO HAS SPACE TO HOLD THAT IN THEIR VAULT?!


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities